Table 1 Demographic details for controls and each FTD patient group.

From: Disruption of macroscale functional network organisation in patients with frontotemporal dementia

Group

N

Site (1:2)

Age

Sex (F:M)

Education

MMSE

Disease Duration

Mutation

miniSEA

Controls

52

18:34

63.6 ± 6.4

27:25

14.9 ± 3.0

29.4 ± 0.8

–

–

26.0 ± 1.48 (N = 28)

bvFTD

42

22:20

65.9 ± 7.7

12:30

14.2 ± 3.9

23.2 ± 4.0

4.2 ± 2.1

5 (C9orf72)

19.2 ± 4.99 (N = 23)

svPPA

17

0:17

64.0 ± 6.7

5:12

14.9 ± 3.0

22.8 ± 7.9

4.5 ± 1.7

–

–

nfvPPA

18

0:17

70.6 ± 8.5

9:9

13.5 ± 2.6

20.9 ± 9.3

3.6 ± 1.5

4 (GRN C31fs)

–

  1. Age and Disease Duration are presented as mean number of years ± standard deviation, MMSE and miniSEA are presented as mean score ± standard deviation, with additional sample size included for miniSEA. Site is presented as number of participants recruited from site 1 to site 2 ratio and sex as number of females to males ratio. Mutation is presented as number of mutation carriers and associated mutation.
  2. bvFTD behavioural variant of FTD, svPPA semantic variant of primary progressive aphasia, nfvPPA non-fluent variant of primary progressive aphasia, MMSE Mini Mental State Examination, C9orf72 expansion repeat in the C9 open reading frame 72 gene, GRN progranulin, miniSEA mini Social Emotional Assessment.
Back to article page